ArticleJournal of arrhythmia2025
High-frequency content within the QRS complex can predict ventricular tachyarrhythmias in hypertrophic cardiomyopathy.
Article in Journal of arrhythmia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- High-frequency content within the QRS complex can predict ventricular tachyarrhythmias in hypertrophic cardiomyopathy.Journal of arrhythmia · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Frequency analysis of the electrocardiographic QRS complex (QRS) was performed to evaluate the abnormal ventricular excitation in hypertrophic cardiomyopathy (HCM), from which we validated a risk stratification for lethal ventricular arrhythmias (L-VAs). Methods: We selected 32 patients with HCM and 60 control subjects from a population of 520 consecutive patients with syncopal seizures in a university hospital. We measured bipolar X, Y, and Z leads and calculated the frequency power using continuous wavelet transform (CWT). We compared frequency powers, ranging from 15 to 250 Hz, between patients with HCM with and without L-VAs. ROC curve analysis was applied to evaluate the differences between groups. Results: The frequency powers of the QRS were increased in HCM in the wide frequency ranges, except for 49-62 Hz. The sum of the frequency power from 150 to 250 Hz was significantly higher in HCM with versus without L-VAs. The area under the ROC curve was 0.83. The occurrence of L-VAs could be predicted with a sensitivity of 0.92 and a specificity of 0.56. Conclusion: The high-frequency power hidden in the QRS may be a valuable predictor of L-VAs in patients with HCM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.